[…]
Rofecoxib (Vioxx) Receives FDA Approval for Treatment of JRA
[…]
Merck Announces Worldwide Voluntary Withdrawal of Vioxx
[…]
Does Reinstituting Anti-TNF Therapy Following Relapse in Remission in RA Have Similar Efficacy?
[…]
Results of TEMPO Trial Now Published
[…]
Incidence of TB in TNF-Treated and TNF-Untreated Patients
[…]
